Weixuan Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Weixuan Wang has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Dan Lu
Peking University Health Science Center
55 shared publications - Wenyu Tian
Institute of Systems Biomedicine, Department of Pharmacology, School of Basic Medical Sciences, National Health Commission Key Laboratory of Medical Immunology, Peking University
55 shared publications - Guangxi Wang
Department of Pathology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking‐Tsinghua Center for Life Sciences, Institute of Systems Biomedicine Peking University Beijing China
54 shared publications - Guangze Zhang
Institute of Systems Biomedicine, Department of Pathology, Center of Basic Medical Research, Institute of Medical Innovation and Research, School of Basic Medical Sciences, Peking-Tsinghua Center for Life Sciences, Peking University Third Hospital, Peking University, Beijing 100191, China
54 shared publications - Limei Guo
Department of Pathology, Peking University Third Hospital, Beijing 100191, China
54 shared publications - Meng Yang
Department of General Surgery, China-Japan Friendship Hospital, Beijing, China
54 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (46)
Loss of DUSP2–RPA signaling enhances virtual memory T cell–mediated innate-like antiviral immunity
Virtual memory CD8 + T (T VM ) cells are antigen-inexperienced cells with rapid effector potential, but how their differentiation and antiviral activity are regulated remains unclear. Here, using an autoantibody-based screening strategy, we identify the phosphatase DUSP2 as a key regulator of T VM cell responses. Dual-specificity phosphatase 2 (DUSP2) deficiency enhances CD8 + T cell–dependent antiviral immunity and promotes the expansion of a highly activated CD44 super-high T VM subset. Upon viral challenge, these T VM cells respond rapidly without antigen recognition and display enhanced effector and cytokine programs, supporting an innate-like mode of antiviral immunity rather than conventional antigen-specific recall. Mechanistically, DUSP2 interacts with the replication protein A (RPA) complex to regulate RPA2 phosphorylation and chromatin association. Disruption of the DUSP2–RPA axis promotes R-loop accumulation and increases chromatin accessibility, which in turn activates Eomesodermin (EOMES)-associated transcriptional programs, eventually promoting T VM cell differentiation. T cell–specific deletion of RPA1 phenocopies these effects, leading to spontaneous T VM cell accumulation and rapid effector-like responses upon viral challenge. Together, our findings establish a DUSP2–RPA–R-loop axis that restrains T VM cell development and innate-like antiviral immunity.
- 9 November 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (46)
Open AccessLoss of DUSP2–RPA signaling enhances virtual memory T cell–mediated innate-like antiviral immunity
Virtual memory CD8 + T (T VM ) cells are antigen-inexperienced cells with rapid effector potential, but how their differentiation and antiviral activity are regulated remains unclear. Here, using an autoantibody-based screening strategy, we identify the phosphatase DUSP2 as a key regulator of T VM cell responses. Dual-specificity phosphatase 2 (DUSP2) deficiency enhances CD8 + T cell–dependent antiviral immunity and promotes the expansion of a highly activated CD44 super-high T VM subset. Upon viral challenge, these T VM cells respond rapidly without antigen recognition and display enhanced effector and cytokine programs, supporting an innate-like mode of antiviral immunity rather than conventional antigen-specific recall. Mechanistically, DUSP2 interacts with the replication protein A (RPA) complex to regulate RPA2 phosphorylation and chromatin association. Disruption of the DUSP2–RPA axis promotes R-loop accumulation and increases chromatin accessibility, which in turn activates Eomesodermin (EOMES)-associated transcriptional programs, eventually promoting T VM cell differentiation. T cell–specific deletion of RPA1 phenocopies these effects, leading to spontaneous T VM cell accumulation and rapid effector-like responses upon viral challenge. Together, our findings establish a DUSP2–RPA–R-loop axis that restrains T VM cell development and innate-like antiviral immunity.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from CD36+ Proinflammatory Macrophages Interact with ZCCHC12+ Tumor Cells in Papillary Thyroid Cancer Promoting Tumor Progression and Recurrence
Table S1 Primers used for quantitative real-time PCR.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from CD36+ Proinflammatory Macrophages Interact with ZCCHC12+ Tumor Cells in Papillary Thyroid Cancer Promoting Tumor Progression and Recurrence
Table S1 Primers used for quantitative real-time PCR.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from CD36+ Proinflammatory Macrophages Interact with ZCCHC12+ Tumor Cells in Papillary Thyroid Cancer Promoting Tumor Progression and Recurrence
Supplementary Table S2 Clinicopathological characteristics of patients for scRNA-seq data.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from CD36+ Proinflammatory Macrophages Interact with ZCCHC12+ Tumor Cells in Papillary Thyroid Cancer Promoting Tumor Progression and Recurrence
Supplementary Table S2 Clinicopathological characteristics of patients for scRNA-seq data.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from CD36+ Proinflammatory Macrophages Interact with ZCCHC12+ Tumor Cells in Papillary Thyroid Cancer Promoting Tumor Progression and Recurrence
Supplementary Table S5 Clinicopathological characteristics of patients used for spatial transcriptome study.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from CD36+ Proinflammatory Macrophages Interact with ZCCHC12+ Tumor Cells in Papillary Thyroid Cancer Promoting Tumor Progression and Recurrence
Supplementary Table S5 Clinicopathological characteristics of patients used for spatial transcriptome study.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Data 4 from CD36+ Proinflammatory Macrophages Interact with ZCCHC12+ Tumor Cells in Papillary Thyroid Cancer Promoting Tumor Progression and Recurrence
Quality inspection form of IHH4
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data 4 from CD36+ Proinflammatory Macrophages Interact with ZCCHC12+ Tumor Cells in Papillary Thyroid Cancer Promoting Tumor Progression and Recurrence
Quality inspection form of IHH4